Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01681745 · ClinicalTrials.gov registry record · NA
Probe Configuration and Time-Temperature Dose Ranging for Understanding of Skin Lesion Effects
A NA study of Histological Response of Tissue to Cold, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT01681745 is a NA study of Histological Response of Tissue to Cold that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01681745, a NA study of Histological Response of Tissue to Cold, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to characterize the biological response of the epidermis, dermis and subcutaneous tissue to treatment with the Myoscience Cryo-Touch III system.
Conditions Studied
Interventions
- DEVICE Cryo-Touch III
Study Locations (1)
California
- 77 Plastic Surgery - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2012-06-01 |
| Est. Completion | 2015-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01681745
The ClinicalTrials.gov registry entry for NCT01681745 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pacira Pharmaceuticals, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Histological Response of Tissue to Cold appearing as the primary indexed condition, and to 1 intervention - of which Cryo-Touch III is the first listed.
NCT01681745 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01681745 about?
NCT01681745 is a clinical study titled "Probe Configuration and Time-Temperature Dose Ranging for Understanding of Skin Lesion Effects". This study is designed to characterize the biological response of the epidermis, dermis and subcutaneous tissue to treatment with the Myoscience Cryo-Touch III system.
What is the current status of trial NCT01681745?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2012-06-01. Estimated completion is 2015-04-01.
What conditions does trial NCT01681745 study?
This clinical trial studies the following conditions: Histological Response of Tissue to Cold.
What interventions are being tested in trial NCT01681745?
The interventions under investigation include: Cryo-Touch III (DEVICE).
Who is sponsoring clinical trial NCT01681745?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01681745 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.